35.5 %Overall, 35.5% of women in the Mobile WAChX trial had incomplete visit coverage.
KenyaVIH/sidapublished 2023Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 6 observations
Gold tier: mechanically validated evidence, with its primary source.
2,235 evidence items · page 52 / 90
35.5 %Overall, 35.5% of women in the Mobile WAChX trial had incomplete visit coverage.
KenyaVIH/sidapublished 2023Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 6 observations
4.3 %The prevalence of viral load non-suppression among treatment-experienced female sex workers in Kenya was 4.3% in 2021.
KenyaVIH/sidaobserved 2021published 2025AIDS (London, England)PubMeddocument of 5 observations
30 %Antiretroviral therapy (ART) uptake among TB patients in Kenya increased from 30% in 2008 to 97% in 2018.
Kenyatuberculose · VIH/sidaobserved 2008published 2022The international journal of tuberculosis and lung disease : the official journal of the IPubMeddocument of 8 observations
17 %Malaria was present in 27 (17%) of 162 HIV-attributed infant or child deaths.
Kenyapaludisme · VIH/sidaobserved Dec 3, 2016 to Dec 31, 2024published 2026The lancet. HIVPubMeddocument of 23 observations
11 patientsEleven patients had nucleoside reverse transcriptase inhibitor resistance mutations, including M184V and T215Y.
KenyaVIH/sidapublished 2022MedicinePubMeddocument of 7 observations
44.3 %The most common HIV testing points identifying HIV-positive children were outpatient departments (44.3%) and maternal/child health departments (29.9%).
KenyaVIH/sidaobserved 2017-2018published 2020PloS onePubMeddocument of 8 observations
8.52 working_daysIn a centralised laboratory-only network, the mean turnaround time ranged from 8.52 to 8.55 working days.
KenyaVIH/sidapublished 2024BMJ openPubMeddocument of 6 observations
16.7 %Systems-level ED-based HIV testing among all presenting patients increased from 16.7% pre-implementation to 23.0% post-implementation periods 1 and 2.
KenyaVIH/sidaobserved 6 March - 16 April 2023 (pre-implementation); 1 May - 20 August 2023 (post-implementation periods 1 and 2)published 2024HIV research & clinical practicePubMeddocument of 4 observations
0.73 adjusted_relative_riskAfter adjusting for age, the relative risk of PSA detection at postmenopausal versus premenopausal visits was 0.73 (95% confidence interval: 0.47 to 1.14).
KenyaVIH/sidapublished 2017Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 5 observations
59 daysTime to completion of at least 3 enhanced adherence counseling sessions was 59.0 days before implementation of the standardized enhanced adherence counseling package.
KenyaVIH/sidapublished 2022MedicinePubMeddocument of 12 observations
401 individualsBetween April 2022 and February 2023, 401 adolescent girls and young women were enrolled after initiating PrEP through their post-abortion care provider in Kenya.
KenyaVIH/sidaobserved April 2022 to February 2023published 2024AIDS and behaviorPubMeddocument of 4 observations
944 partnersAmong 2176 partners in the post-implementation period, 944 were offered a second HIV self-test (HIVST).
KenyaVIH/sidaobserved March 2021-June 2022published 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 5 observations
The Tambua Mapema Plus study was conducted in Kenya from 2017 to 2020.
KenyaVIH/sidaobserved 2017-2020published 2022BMJ openPubMeddocument of 8 observations
33.7 daysVihiga County had the shortest mean DNA-PCR turnaround time at 33.7 days in Vihiga, Bungoma, Kakamega and Busia counties in Kenya between January 2012 and June 2013.
KenyaVIH/sidaobserved January 2012 to June 2013published 2024PloS onePubMeddocument of 7 observations
2.89 aHRAmong patients switching to dolutegravir-containing regimens, those without a recent viral load test or with a preswitch viral load ≥1000 copies/mL had an adjusted hazard ratio of 2.89 for incident viral load ≥1000 copies/mL compared to those with preswitch viral load <200 copies/mL.
KenyaVIH/sidapublished 2022Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument of 6 observations
65 %In Kenya, the viral load testing uptake among paediatric and adolescent patients improved from 65% to 96%.
KenyaVIH/sidapublished 2021BMC health services researchPubMeddocument of 5 observations
11 prevalence_ratioThe prevalence ratio for experienced stigma associated with self-disclosure was 11.0 (95% CI: 1.4–86).
KenyaVIH/sidapublished 2021AIDS and behaviorPubMeddocument of 13 observations
82 %For 851 children eligible for testing, the most common reason for having an unknown HIV status was that the child's mother was not tested for HIV or had tested HIV negative during pregnancy (82%).
KenyaVIH/sidapublished 2020Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 7 observations
28.3 pg/mlThe median (IQR) levels of IFN-γ were 28.3 (23.5–31.2) pg/ml in pLLV participants and 11.4 (8.8–14.8) pg/ml in virally suppressed participants on first-line cART.
KenyaVIH/sidapublished 2025The Pan African medical journalPubMeddocument of 11 observations
22 yearsThe median age of 399 participants enrolling into an HIV incidence cohort in Kenya was 22 years, with an interquartile range of 19–24 years.
KenyaVIH/sidapublished 2024Journal of the International AIDS SocietyPubMeddocument of 6 observations
5,500 patientsOf the 5,500 people living with HIV aged ≥15 years on first-line antiretroviral therapy at one health facility in Kenya, 4,233 (77%) had transitioned to optimized antiretroviral drugs.
KenyaVIH/sidapublished 2020PloS onePubMeddocument of 4 observations
22 %In 2013, 22% of participants in the African Cohort Study (AFRICOS) reported HIV stigma at the enrollment visit.
KenyaVIH/sidaobserved 2013published 2022AIDS carePubMeddocument of 4 observations
1.11 aIRRIn the female sex worker cohort, there was no association between schistosomiasis and HIV-1 acquisition risk (adjusted incidence rate ratio = 1.11, 95% CI 0.83 to 1.50).
Kenyaschistosomiase · VIH/sidapublished 2020Journal of the International AIDS SocietyPubMeddocument of 13 observations
1.2 %Among the studied cohort, the HIV positivity rate at initial test was 1.2%.
KenyaVIH/sidapublished 2021BMC public healthPubMeddocument of 11 observations
539 individuals539 (69%) of enrolled people living with HIV were female.
KenyaVIH/sidapublished 2022PloS onePubMeddocument of 15 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.